A radiation oncologist is a specialized cancer doctor who administers the controlled use of radiation therapy to fight and cure cancer. Radiation therapy is a highly effective tool in treating a broad range of cancers, especially in conjunction with other treatments such as surgery and chemotherapy. A radiation oncologist is a key member of a multi-disciplinary cancer team.
Dr. Kendra M. Harris MD is a female radiation oncologist in New Orleans, LA with over 12 years of experience. Dr. Harris graduated from Johns Hopkins University School of Medicine in 2008. She is licensed to practice by the state board in Louisiana.
I became a radiation oncologist to bring the best in the world care to the patients in front of me. That means the latest and greatest equipment and team, access to clinical trials, a multi-disciplinary focus and strong communication so we can together set the path.
Dr. Harris treats the following 37 conditions
Basal Cell Carcinoma Of The Skin
Base Of Tongue Cancer
Diffuse Large B Cell Lymphoma
Left-sided Breath Hold Breast Radiation Treatment
Metastasis-Directed Liver Stereotactic Body Radiotherapy
Non-Small Cell Lung Cancer
PSMA-linked Clinical Trials For Radiopharmaceuticals
Small Cell Lung Cancer
Soft Tissue Sarcomas
Squamous Cell Carcinoma Of The Skin
Stereotactic Ablative Radiotherapy
Stereotactic Body Radiotherapy
Total Body Irradiation
Total Skin Electron Therapy
Kendra Harris, MD, MSc, joined Tulane University School of Medicine’s Department of Radiation Oncology in July 2018. Dr. Harris is board-certified in radiation oncology and radiobiology. She earned her medical degree from Johns Hopkins University School of Medicine and completed her residency in the Department of Radiation Oncology and Molecular Radiation Sciences at Johns Hopkins. She also completed a fellowship in patient safety at the Armstrong Institute for Patient Safety and Quality. Prior to joining Tulane, Dr. Harris practiced at Orlando Health UF Health Cancer Center where she treated patients with proton therapy, photon therapy and high dose rate brachytherapy and served as PI for a number of clinical trials. She is also currently fulfilling a three-year appointment on the Metastatic/ Recurrent Task Force with the National Cancer Institute Coordinating Center for Clinical Trials. Dr. Harris has been published in multiple journals on issues related to patient safety and is a member of the American Society for Therapeutic Radiology and Oncology (ASTRO). In 2002, prior to medical school, she was selected as a Rhodes Scholar and completed a Master of Science (MSc) degree focused on health care policy at Oxford University, and in 2013, she earned the Frank L. Coulson Award for Clinical Excellence from the Johns Hopkins University School of Medicine.